Tag: ARV
Cipla & DNDi launch child-friendly 4-in-1 antiretroviral treatment in South Africa
This new formulation represents a significant improvement over protease inhibitor-containing paediatric ARV formulations that have been used in South Africa for decades
DCGI’s green signal to Mylan’s launch of Avonza in India
The new drug by Mylan offers an innovative, reduced-dose alternative first-line regimen for people being treated for HIV/AIDS in India.........